Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology

Open access
Dhabhar, Firdaus S.·2009·Neuroimmunomodulation

Abstract

Stress is known to suppress immune function and increase susceptibility to infections and cancer. Paradoxically, stress is also known to exacerbate asthma, and allergic, autoimmune and inflammatory diseases, although such diseases should be ameliorated by immunosuppression. Moreover, the short-term fight-or-flight stress response is one of nature’s fundamental defense mechanisms that enables the cardiovascular and musculoskeletal systems to promote survival, and it is unlikely that this response would suppress immune function at a time when it is most required for survival (e.g. in response to wounding and infection by a predator or aggressor). These observations suggest that stress may suppress immune function under some conditions while enhancing it under others. The effects of stress are likely to be beneficial or harmful depending on the type (immunoprotective, immunoregulatory/inhibitory, or immunopathological) of immune response that is affected. Studies have shown that several critical factors influence the direction (enhancing vs. suppressive) of the effects of stress or stress hormones on immune function: (1) Duration (acute vs. chronic) of stress: Acute or short-term stress experienced at the time of immune activation can enhance innate and adaptive immune responses. Chronic or long-term stress can suppress immunity by decreasing immune cell numbers and function and/or increasing active immunosuppressive mechanisms (e.g. regulatory T cells). Chronic stress can also dysregulate immune function by promoting proinflammatory and type-2 cytokine-driven responses. (2) Effects of stress on leukocyte distribution: Compartments that are enriched with immune cells during acute stress show immunoenhancement, while those that are depleted of leukocytes, show immunosuppression. (3) The differential effects of physiologic versus pharmacologic concentrations of glucocorticoids, and the differential effects of endogenous versus synthetic glucocorticoids: Endogenous hormones in physiological concentrations can have immunoenhancing effects. Endogenous hormones at pharmacologic concentrations, and synthetic hormones, are immunosuppressive. (4) The timing of stressor or stress hormone exposure relative to the time of activation and time course of the immune response: Immunoenhancement is observed when acute stress is experienced at early stages of immune activation, while immunosuppression may be observed at late stages of the immune response. We propose that it is important to study and, if possible, to clinically harness the immunoenhancing effects of the acute stress response, that evolution has finely sculpted as a survival mechanism, just as we study its maladaptive ramifications (chronic stress) that evolution has yet to resolve. In view of the ubiquitous nature of stress and its significant effects on immunoprotection as well as immunopathology, it is important to further elucidate the mechanisms mediating stress-immune interactions and to meaningfully translate findings from bench to bedside.

Overview

Integrity signals

Registry

Crossref · 10.1159/000216188

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 163 references

Research works printed but not linked: 4

  1. 10.1210%2Fen.135.5.1934 · doi:10.1210/en.135.5.1934 · Paper page
  2. 10.1146%2Fannurev.iy.05.040187.003201 · doi:10.1146/annurev.iy.05.040187.003201 · Paper page
  3. 10.1210%2Fen.135.6.2351 · doi:10.1210/en.135.6.2351
  4. 10.1210%2Fen.137.10.4260 · doi:10.1210/en.137.10.4260

Cited by

See all 903

Metadata

Authors
Dhabhar, F. S.
Affiliations
Stanford Medicine (US)
Corresponding author
Dhabhar, Firdaus S.
Venue
Neuroimmunomodulation
Publisher
S. Karger AG
Published
2009
Volume
16
Issue
5
Pages
300-317
ISSN
  • 1021-7401 (ISSN-L)
  • 1423-0216
OpenAlex
W2026429915
Cited by
903
References
163
Citations by year
2026: 32 · 2025: 44 · 2024: 50 · 2023: 44 · 2022: 67 · 2021: 56 · 2020: 70 · 2019: 59 · 2018: 53 · 2017: 74 · 2016: 48 · 2015: 43 · 2014: 67 · 2013: 62 · 2012: 58
FWCI
2.40
Type
journal article
Language
en
Open access
Licence
Locations
  • NeuroImmunoModulation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Dana Foundation (AI48995, CA107498)
  • National Institutes of Health
  • National Cancer Institute (R01CA107498)
  • National Institute of Allergy and Infectious Diseases (R01AI048995)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
Keywords
stress, immune function, immune enhancement, immunosuppression, acute stress response, chronic stress, glucocorticoids, stress hormones, regulatory T cells, leukocyte distribution, innate and adaptive immunity, immunopathology, immunoprotection, asthma, autoimmune disease, inflammatory diseases, infection susceptibility, cancer susceptibility, cytokine imbalance
MeSH terms
Adaptation, Physiological, Animals, Chronic Disease, Glucocorticoids, Humans, Immune System, Immune Tolerance, Immunity, Innate, Immune System Diseases, Stress, Physiological, Neuroimmunomodulation, Up-Regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology. https://app.cochat.ai/papers/10.1159/000216188
The paper
Dhabhar, F. S. (2009). Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology. Neuroimmunomodulation. https://doi.org/10.1159/000216188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.